Mechanisms of glutamate metabolic function and dysfunction in vascular dementia

Jiawen Wang1, Yingmei Zhang1,2, Ning Tian1

  • 1Laboratory of Neuroscience, Affiliated Hospital of Guilin Medical University Guilin Medical University Guilin Guangxi China.

Neuroprotection (Chichester, England)
|December 12, 2025
PubMed

Insights

Vascular dementia (VaD) involves brain blood supply issues. This study explores how regulating glutamate metabolism may offer new prevention and treatment strategies for VaD.

Area of Science:

  • Neuroscience
  • Neurology
  • Gerontology

Background:

  • Dementia research is crucial as global populations age.
  • Vascular dementia (VaD) is the second most common dementia type, stemming from impaired brain blood supply.
  • VaD presents complex neurological and behavioral challenges.

Purpose of the Study:

  • To investigate the link between vascular dementia and glutamate metabolism.
  • To explore glutamate metabolism regulation as a potential therapeutic target for VaD.
  • To identify improved methods for VaD prevention and treatment.

Main Methods:

  • Review of existing literature on VaD pathogenesis.
  • Analysis of the role of glutamate in brain function and dysfunction.
  • Exploration of the connection between cerebral hypoperfusion and glutamate excitotoxicity.

Main Results:

  • Reduced brain blood flow in VaD contributes to excessive glutamate accumulation.
  • Glutamate excitotoxicity is a key mechanism leading to neuronal death in VaD.
  • Abnormal glutamate metabolism is strongly associated with dementia development.

Conclusions:

  • Regulating glutamate metabolism presents a promising avenue for VaD treatment.
  • Targeting glutamate pathways could lead to novel strategies for preventing and managing VaD.
  • Further research into glutamate's role is essential for advancing VaD therapies.

Related Concept Videos

Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.4K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
857
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.7K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.0K